Melanoma International Collaborative Adaptive Trials: Progress Report
The first adaptive platform trial in melanoma—and one of the only adaptive platform trials that will be in existence for…
Blog - Melanoma360
11/13/2018
Melanoma International Collaborative Adaptive Trials: Progress Report
The first adaptive platform trial in melanoma—and one of the only adaptive platform trials that will be in existence for…
|
|
11/13/2018
Melanoma Legislation: Progress Report
The facts are straightforward: Indoor tanning before 18 years of age increases one’s risk of melanoma by 85%,1 and the…
|
11/13/2018
Global Advocacy: Progress Report
Melanoma is a global disease. In the United States, one person dies every 54 minutes from melanoma. Australia and New…
|
11/13/2018
The Melanoma Tissue Bank: Progress Report
As we look back through 2018, perhaps the most exciting news from AIM at Melanoma is the progress on what…
|
|
10/08/2018
Grocery Shopping Tips for Melanoma Caregivers
Shop with a list: Make copies of a standard a grocery list that can be added to each week which includes…
|
09/05/2018
In Plain English: The Keynote 716 Clinical Trial
As of this writing, there are 477 clinical trials in melanoma on ClinicalTrial.gov that are actively recruiting patients—and another 65…
|
09/04/2018
Q&A With Three Leading Melanoma Specialists
Eric D. Whitman, MD Medical Director, Atlantic Health System Cancer Care Director, Atlantic Melanoma Center Question: Which clinical trials do…
|
08/30/2018
Melanoma By The State: Vermont
Vermont is a state known for national and state forests, majestic snow-covered mountains, delicious maple syrup, and Ben and Jerry’s…
|
04/26/2018
Jonathan Swingle, The Mucosal Melanoma Warrior
2009 was not a good year for Jonathan Swingle. Multiple nosebleeds led Jonathan to seek his doctor’s help, which…
|
07/31/2018
AIM Announces New Partnership With The Society for Immunotherapy of Cancer (SITC)
AIM at Melanoma is proud to announce our new online educational partnership with the Society for Immunotherapy of Cancer…
|
Recent Posts
Nov. 22, 2024
Replimune Receives Breakthrough Therapy Designation for RP1 and Submits BLA to FDA
Nov. 22, 2024
Meaning-Centered Psychotherapy for Cancer Patients
Nov. 05, 2024
Crafting Hope: Chris Krizek’s Journey from Cancer Patient to AIM Fundraiser with Wine Cork Creations
Nov. 04, 2024
Book Suggestions for Caregivers
Oct. 28, 2024